Sensei Biotherapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1999-01-01
- Employees
- 27
- Market Cap
- -
- Website
- http://senseibio.com
- Introduction
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
Sensei Biotherapeutics to Participate in Citi's 2024 Global Healthcare Conference
Sensei Biotherapeutics to participate in Citi’s 2024 Global Healthcare Conference on Dec 3-5 in Miami, FL. Focused on developing next-gen cancer therapeutics via TMAb™ platform.
© Copyright 2024. All Rights Reserved by MedPath